Glial-restricted precursors as potential candidates for ALS cell-replacement therapy

• Autorzy: Kruminis-Kaszkiel E. , Wojtkiewicz J. , Maksymowicz W.
• Języki publikacji: EN

Abstrakty

EN

Amyotrophic lateral sclerosis is a multifactorial progressive neurodegenerative disorder leading to severe disability and death within 3-5 years after diagnosis. The main mechanisms underlying the disease progression are poorly known but according to the current knowledge, neuroinflammation is a key player in motor neurons damage. Astrocytes constitute an important cell population involved in neuroinflammatory reaction. Many studies confirmed their striking connection with motor neuron pathology and therefore they might be a target for the treatment of ALS. Cell-based therapy appears to be a promising strategy. Since direct replacement or restoring of motor neurons using various stem cells is challenging, enrichment of healthy donor-derived astrocytes appears to be a more realistic and beneficial approach. The effects of astrocytes have been examined using transplantation of glial-restricted precursors (GRPs) that represent one of the earliest precursors within the oligodendrocyte and astrocytic cell lineage. In this review, we focused on evidence-based data on astrocyte replacement transplantation therapy using GRPs in animal models of motor neuron diseases. The efficacy of GRPs engrafting is very encouraging. Furthermore, the lesson learned from application of lineage-restricted precursors in spinal cord injury (SCI) indicates that differentiation of GRPs into astrocytes before transplantation might be more advantageous in the context of axon regeneration. To sum up, the studies of glial-restricted precursors have made a step forward to ALS research and might bring breakthroughs to the field of ALS therapy in the future.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2014
• Tom: 74
• Numer: 3
• Opis fizyczny: p.233-241,fig.,ref.

Twórcy

autor

Kruminis-Kaszkiel E.

• Department of Phatophysiology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland

autor

Wojtkiewicz J.

• Department of Phatophysiology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
• Department of Neurology and Neurosurgery, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland

autor

Maksymowicz W.

• Department of Neurology and Neurosurgery, Faculty of Medical Sciences, University of Warmia and Mazury, Olsztyn, Poland

Bibliografia

• Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9: 617-628.
• Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, Estevez AG, Beckman JS (2004) A role for astro¬cytes in motor neuron loss in amyotrophic lateral sclero¬sis. Brain Res Brain Res Rev 47: 263-274.
• Bensimon G, Lacomblez L, Meininger V (1994) A con¬trolled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 330: 585¬591.
• Cabanes C, Bonilla S, Tabares L, Martinez S (2007) Neuroprotective effect of adult hematopoietic stem cells in a mouse model of motoneuron degeneration. Neurobiol Dis 26: 408-418.
• Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ (2006) Astrocytes derived from glial-restrict- ed precursors promote spinal cord repair. J Biol 5: 7.
• Davies JE, Proschel C, Zhang N, Noble M, Mayer-Proschel M, Davies SJ (2008) Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 7: 24.
• Davies SJ, Shih CH, Noble M, Mayer-Proschel M, Davies JE, Proschel C (2011) Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 6: e17328.
• Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221.
• Gordeeva OF, Nikonova TM (2013) Development of exper¬imental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice. Cell Transplant 22: 1901-1914.
• Gordon PH (2013) Amyotrophic lateral sclerosis: An update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis 4: 295-310.
• Gregori N, Proschel C, Noble M, Meyer-Proschel M (2002) The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipo¬tential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J Neurosci 22: 248-256.
• Haas C, Fischer I (2013) Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord. J Neurotrauma 30: 1035-1052.
• Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust
• KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AH, Kaspar BK (2011) Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 29: 824-828.
• Han SS, Liu Y, Tyler-Polsz C, Rao MS, Fischer I (2004) Transplantation of glial-restricted precursor cells into the adult spinal cord: survival, glial-specific differentiation, and preferential migration in white matter. Glia 45: 1-16.
• Henriques A, Pitzer C, Schneider A (2010) Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: Where do we stand? Front Neurosci 4: 32.
• Jin Y, Neuhuber B, Singh A, Bouyer J, Lepore A, Bonner J, Himes T, Campanelli JT, Fischer I (2011) Transplantation of human glial restricted progenitors and derived astro¬cytes into a contusion model of spinal cord injury. J Neurotrauma 28: 579-594.
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574.
• Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE (2010) NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and follow¬ing neurodegeneration. Neuron 68: 668-681.
• Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda- Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S (2010) Safety and immunological effects of mesenchymal stem cell trans¬plantation in patients with multiple sclerosis and amyo¬trophic lateral sclerosis. Arch Neurol 67: 1187-1194.
• Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O (2005) Human embryonic stem cell- derived oligodendrocyte progenitor cell transplants remy- elinate and restore locomotion after spinal cord injury. J Neurosci 25: 4694-4705.
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377: 942-955.
• Kim H, Walczak P, Kerr C, Galpoththawela C, Gilad AA, Muja N, Bulte JW (2012) Immunomodulation by trans¬planted human embryonic stem cell-derived oligodendro- glial progenitors in experimental autoimmune encephalo- myelitis. Stem Cells 30: 2820-2829.
• Kiskinis E, Eggan K (2010) Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
• Kondo T, Raff M (2000) oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289: 1754-1757.
• Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak- Vance MA, Yan J, Ticozzi N, Siddique T, McKenna- Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323: 1205-1208.
• Lee H, Shamy GA, Elkabetz Y, Schofield CM, Harrsion NL, Panagiotakos G, Socci ND, Tabar V, Studer L (2007) Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 25: 1931-1939.
• Lepore AC, Fischer I (2005) Lineage-restricted neural pre¬cursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol 194: 230-242.
• Lepore AC, Han SS, Tyler-Polsz CJ, Cai J, Rao MS, Fischer I (2004) Differential fate of multipotent and lineage-re¬stricted neural precursors following transplantation into the adult CNS. Neuron Glia Biol 1: 113-126.
• Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ (2008) Focal transplanta¬tion-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11: 1294¬1301.
• Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ (2011) Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 6: e25968.
• Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, Pearce RA, Zhang SC (2005) Specification of motoneu- rons from human embryonic stem cells. Nat Biotechnol 23: 215-221.
• Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81: 385-390.
• MacDonald SC, Fleetwood IG, Hochman S, Dodd JG, Cheng GK, Jordan LM, Brownstone RM (2003) Functional motor neurons differentiating from mouse multipotent spinal cord precursor cells in culture and after transplan¬tation into transected sciatic nerve. J Neurosurg 98: 1094-1103.
• Maragakis NJ, Rao MS, Llado J, Wong V, Xue H, Pardo A, Herring J, Kerr D, Coccia C, Rothstein JD (2005) Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitro. Glia 50: 145— 159.
• Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3: 649¬657.
• Markiewicz I, Lukomska B (2006) The role of astrocytes in the physiology and pathology of the central nervous sys¬tem. Acta Neurobiol Exp (Wars) 66: 343-358.
• Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-622.
• Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996) Co-localization of NG2 proteoglycan and PDGF alpha-receptor on O2A progenitor cells in the developing rat brain. J Neurosci Res 43: 299-314.
• Noble M, Davies JE, Mayer-Proschel M, Proschel C, Davies SJ (2011) Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics 8: 677-693.
• Papadeas ST, Kraig SE, O'Banion C, Lepore AC, Maragakis NJ (2011) Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc Natl Acad Sci U S A 108: 17803-17808.
• Pastor D, Viso-León MC, Jones J, Jaramillo-Merchán J, Toledo-Aral JJ, Moraleda JM, Martínez S (2012) Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model. Stem Cell Rev 8: 445-458.
• Perez-Bouza A, Glaser T, Brüstle O (2005) ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions. Brain Pathol 15: 208¬216.
• Philips T, Robberecht W (2011) Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10: 253-263.
• Raff MC, Miller RH, Noble M (1983) A glial progenitor cell that develops in vitro into an astrocyte or oligodendrocyte depending on culture medium. Nature 303: 390¬396.
• Rao MS (1999) Multipotent and restricted precursors in the central nervous system. Anat Record 257: 137-148.
• Rao MS, Mayer-Proschel M (1997) Glial-Restricted precur¬sors are derived from multipotent neuroepithelial stem cells. Dev Biol 188: 48-63.
• Rao MS, Noble M, Mayer-Proschel M (1998) A tripotential glial precursor cells is present in developing spinal cord. Proc Natl Acad Sci U S A 95: 3996-4001.
• Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E (2013) Cellular therapy to target neuroin¬flammation in amyotrophic lateral sclerosis. Cell Mol Life Sci 71: 999-1015.
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
• Rothstein MD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65 (Suppl 1): S3-9.
• Sharp J, Frame J, Siegenthaler M, Nistor G, Keirstead HS (2010) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 28: 152-163.
• Sypecka J, Sarnowska A (2013) Heterogeneity of local tis¬sue microenvironment influences differentiation of oligodendroglial progenitors. Folia Neuropathol 51: 103-110.
• Sypecka J, Sarnowska A, Gadomska-Szablowska I, Lukomska B, Domanska-Janik K (2013) Differentiation of glia-committed NG2 cells: the role of factors released from hippocampus and spinal cord. Acta Neurobiol Exp (Wars) 73: 117-130.
• Ticozzi N, Tiloca C, Morelli C, Colombrita C, Poletti B, Doretti A, Maderna L, Messina S, Ratti A, Silani V (2011) Genetics of familial Amyotrophic lateral sclerosis. Arch Ital Biol 149: 65-82.
• Totoiu MO, Nistor GI, Lane TE, Keirstead HS (2003) Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 187: 254-265.
• Vargas MR, Pehar M, Cassina P, Martínez-Palma L, Thompson JA, Beckman JS, Barbeito L (2005) Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem 280: 25571-25579.
• Wang Y, Piao JH, Larsen EC, Kondo Y, Duncan ID (2011) Migration and remyelination by oligodendrocyte pro¬genitor cells transplanted adjacent to focal areas of spinal cord inflammation. J Neurosci Res 89: 1737-1746.
• Xu L, Shen P, Hazel T, Johe K, Koliatsos VE (2011) Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett 494: 222-226.
• Yan J, Xu L, Welsh AM, Chen D, Hazel T, Johe K, Koliatsos VE (2006) Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lat¬eral sclerosis transgenic mice. Stem Cells 24: 1976¬1985.
• Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJ (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6: 578-590.